cell-therapy

Documents about cell-therapy

• Mesenchymal stromal cell therapy is a long-term regenerative approach for chronic radiation cystitis, involving coordinated modulation of the urothelial, immune, vascular, and fibrotic pathways#350601HAL (France)
• Vaccine Therapy With or Without Interleukin-2 After Chemotherapy and an Autologous White Blood Cell Infusion in Treating Patients With Metastatic Melanoma#356540ClinicalTrials.gov
• pH/ROS Dual-Responsive Zwitterionic Polymer Micelles with Enhanced Mucus Penetration for Bacterial Pneumonia Therapy#374088Figshare
• Socioeconomic Determinants of Guideline-Concordant Therapy for Early-Stage Non-Small Cell Lung Cancer: A Population-Based Analysis from Appalachian and Non-Appalachian Ohio, 2004-2015#390893bioRxiv / medRxiv
• Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and Fever#429771ClinicalTrials.gov
• A Phase Ⅱ Trials of Sintilimab as Consolidation Therapy After Radical Concurrent Chemoradiotherapy in Locally Advanced Unresectable ESCC#824772ClinicalTrials.gov
• UCAR T-cell Therapy Targeting CD19/ BCMA(QT-019C) in Patients With Relapse/ Refractory Autoimmune Diseases#834960ClinicalTrials.gov
• Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC#849286ClinicalTrials.gov
• Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Optic Nerve Disease#854734ClinicalTrials.gov
• To Evaluate the Correlation Between the Results of Specific Gene Testing and the Efficacy of Targeted Therapy in Patients With NSCLC#860011ClinicalTrials.gov
• Blastic Plasmacytoid Dendritic Cell Neoplasm: A Single-Center Experience. Clinical Characterization, Mutational Landscape, and Clinical Outcome of Patients Undergoing Hematopoietic Stem Cell Transplantation Intensive Therapy#651442Dipòsit Digital de la Universitat de Barcelona
• A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)#807635ClinicalTrials.gov
• Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer#829010ClinicalTrials.gov
• Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)#830801ClinicalTrials.gov
• Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)#839229ClinicalTrials.gov
• Hypofractionated Radiation Therapy After Durvalumab and Chemotherapy for the Treatment of Stage IV Extensive Stage Small Cell Lung Cancer, CASPIAN-RT Trial#184851ClinicalTrials.gov
• Testing the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung Cancer#460080ClinicalTrials.gov
• Study of a Strategy Integrating Adjuvant Radiation Therapy Versus Strategy Based on Monitoring in the Treatment of Carcinomas Spinocellular With High Risk of Recurrence#839092ClinicalTrials.gov
• Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer#862627ClinicalTrials.gov
• T Cell Inflamed Gene Expression Profiling Score-guided Anti PD-1 Therapy (Tislelizumab Monotherapy) for Refractory Solid Cancer Patients Unexposed to Immunotherapy#154647ClinicalTrials.gov
• Bio-inspired Solid Lipid Nanoparticles for therapeutic siRNA delivery targeting the LRRK2 G2019S mutation in a Parkinson’s disease cell model.#215983ResearchSpace
• Mesenchymal stromal cell therapy is a long-term regenerative approach for chronic radiation cystitis, involving coordinated modulation of the urothelial, immune, vascular, and fibrotic pathways.#251177NCBI PubMed Central
• Supplemental Material for: Rapid Regression of Choroidal Metastasis Under First-Line Osimertinib Therapy in EGFR-Mutated Non–Small Cell Lung Cancer: A Case Report#436092Figshare
• Electromagnetic transduction therapy (EMTT) enhances tenocyte regenerative potential: evidence for senolytic-like effects and matrix remodeling#458500IRIS
• Lipoprotein apheresis as rescue therapy in lipoprotein glomerulopathy: The role of plasmatic extracellular vesicle removal#476184IRIS
• A Study of Treatment Patterns and Outcomes in Participants With Stage IIIA Melanoma Receiving Adjuvant Systemic Therapy#841496ClinicalTrials.gov
• A Phase II Study of Anti-PD-1 Antibody, Sintilimab, as Second-line Therapy for Biomarker-selected Advanced or Metastatic NSCLC#843602ClinicalTrials.gov
• BGC101 (EnEPC) Autologous Cell Therapy From Patient's Own Blood for Treatment of Critical Limb Ischemia (CLI)#861255ClinicalTrials.gov
• Chimeric Antigen Receptor Natural Killer Cell Therapy for High-risk Lymphoma Patients With Primary Sjogren's Syndrome#865027ClinicalTrials.gov
• Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer#623527ClinicalTrials.gov
• Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck#828876ClinicalTrials.gov
• Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)#827828ClinicalTrials.gov
• Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer#804902ClinicalTrials.gov
• Community Opioid Overdose Prevention and Naloxone Distribution Programs: An Evidence-to-Practice Review#365484Scholar Commons
• B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)#143576ClinicalTrials.gov
• Cellules souches adultes MuStem humaines : potentiel thérapeutique dans un contexte d’infarctus du myocarde et vésicules extracellulaires#238926HAL (France)
• Supporting data for "Pt1a and tyrosine kinase inhibitor combination treatment exerts synergistic anti-hepatocellular carcinoma effect through RNA m6A methylation modification".#344096Figshare
• T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers#474750ClinicalTrials.gov
• Study to Evaluate the Efficacy and Safety of Tenalisib, Given With CHOP Therapy for Front Line Treatment in Patients With PTCL#807627ClinicalTrials.gov
• Local Injection and Systemic Therapy in the Treatment of NSCLC.#824927ClinicalTrials.gov
• Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC#829118ClinicalTrials.gov
• An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI)#833241ClinicalTrials.gov
• Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIM#852492ClinicalTrials.gov
• Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients#861188ClinicalTrials.gov
• Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP#152411ClinicalTrials.gov
• Olaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO Trial#444874ClinicalTrials.gov
• Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation#839578ClinicalTrials.gov
• Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis#849820ClinicalTrials.gov
• Comparison of the Effect of Surgical Resection Based on Lesion Extent Before and After Neoadjuvant Therapy in Patients With Stage II-IIIB Non-Small Cell Lung Cancer: A Single-Center, Real-World, Open-Label Study#474747ClinicalTrials.gov
• CD19: A Biomarker For B Cell Development, Lymphoma Diagnosis And Therapy#19596OpenCitations